REVERSE TRIIODOTHYRONINE (T3) - ANVISA Registration 80102511895

Access comprehensive regulatory information for REVERSE TRIIODOTHYRONINE (T3) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102511895 and manufactured by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80102511895
Registration Details
ANVISA Registration Number: 80102511895
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

MAGLUMI REV T3 (CLIA)
Risk Class II

Registration Details

80102511895

25351303352201770

04718143000194

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Oct 23, 2017

VIGENTE

09/18/2025 19:00:01